Co-Therapy of Albendazole and Dexamethasone Reduces Pathological Changes in the Cerebral Parenchyma of Th-1 and Th-2 Dominant Mice Heavily Infected with Angiostrongylus cantonensis: Histopathological and RNA-seq Analyses-MedSci.cn

Co-Therapy of Albendazole and Dexamethasone Reduces Pathological Changes in the Cerebral Parenchyma of Th-1 and Th-2 Dominant Mice Heavily Infected with Angiostrongylus cantonensis: Histopathological and RNA-seq Analyses

Jhan, KY; Cheng, CJ; Jung, SM; Lai, YJ; Chen, KY; Wang, LC

Wang, LC (corresponding author), Chang Gung Univ, Grad Inst Biomed Sci, Coll Med, Taoyuan 333, Taiwan.; Wang, LC (corresponding author), Chang Gung Univ, Dept Parasitol, Coll Med, Taoyuan 333, Taiwan.; Chen, KY (corresponding author), China Med Univ, Sch Med, Dept Parasitol, Taichung 404, Taiwan.; Wang, LC (corresponding author), Chang Gung Mem Hosp, Mol Infect Dis Res Ctr, Taoyuan 333, Taiwan.

Abstract

Administration of albendazole alone was not very suitable for the treatment of cerebral angiostrongyliasis. This study was designed to evaluate the ef......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Co-Therapy of Albendazole and Dexamethasone Reduces Pathological Changes in the Cerebral Parenchyma of Th-1 and Th-2 Dominant Mice Heavily Infected with Angiostrongylus cantonensis: Histopathological and RNA-seq Analyses

科室

工具

服务